Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV002251837 | SCV002522533 | likely pathogenic | not provided | 2021-04-07 | criteria provided, single submitter | clinical testing | PM2, PVS1 |
Myriad Genetics, |
RCV004565250 | SCV004044785 | pathogenic | Familial adenomatous polyposis 1 | 2023-04-27 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |